Endomag wins King’s Award for Enterprise for International Trade 2024
This latest acknowledgement celebrates Endomag’s continued excellence in international trade growth over recent years.
Following on from two previous Queen’s Award for Enterprise wins in 2018 for Innovation and 2021 for International Trade, we are honoured to have been recognised once again for impressive growth in the UK and overseas with a 2024 King's Award for Enterprise.
The King’s Awards for Enterprise were renamed last year to reflect His Majesty The King’s desire to continue the legacy of HM Queen Elizabeth II by recognising outstanding UK businesses making a difference in their fields.
“We are extremely proud to win our first King’s Award, following on from our previous success with the Queen’s Awards, this time recognising our efforts for outstanding short term international growth. Since first launching our products in the UK almost a decade ago, our team has built and established an impressive trading footprint, continuing to grow our markets across EMEA, North America and Australasia"Dr. Eric Mayes, CEO at Endomag
The Award programme, now in its 58th year, is one of the most prestigious business awards in the country, with successful businesses receiving the esteemed King’s Awards Emblem for the next five years.
“We’re delighted that our medical device technologies have now been able to help over 485,000 women in over 45 countries access a better standard of care. Winning this award is a huge honour, re-affirming our dedication to positively impacting the lives of individuals affected by breast cancer”Dr. Eric Mayes, CEO at Endomag
The Sentimag® platform, alongside Magseed® and Magtrace®, allows a breast cancer patient to be treated every four minutes on average, somewhere in the world.
We are honoured to have received this latest recognition as we continue to develop world-leading technologies, harnessing the power of magnetic sensing to help empower clinicians and patients across the world.